FindTrial
Sign In

The effect of the transdermal acetylcholine esterase inhibitors on frontal lobe function in Alzhemer's disease patients

The effect of the transdermal acetylcholine esterase inhibitors on frontal lobe function in Alzhemer's disease patients - The effect of the transdermal acetylcholine esterase inhibitors on frontal lobe function

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014319
Enrollment
50
Registered
2014-06-19
Start date
2014-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&#39

Interventions

The transdermal acetylcholine esteras inhibitors

Sponsors

Keio University
Lead Sponsor
The Salvation Army Booth Mental Hospital Tsutsuji-Mental Hospital Ashikari clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are diagnosed mild to moderate Alzheimer's disease(MMSE10-23 and CDR 0.5-2) Naive patients for AD treatments patients swithching from donepezil/galatamine(requiring wash out for 4weeks),if necessary. Male and female AD patients basically outpatients,how ever inpatients can be included if necessary

Exclusion criteria

Exclusion criteria: Severa AD patients(MMSE<10)

Design outcomes

Primary

MeasureTime frame
CPT test and memory updating test (part of CAT)—

Countries

Japan

Contacts

Public ContactHajime tabuchi

Keio University Department of Neuropsychiatry

tabuchi@a8.keio.jp0353633829

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026